Abstract #999926: Effect of Dosing and Titration of Osilodrostat on Efficacy and Safety in Patients With Cushing's Disease (CD): Results From Two Phase III Trials (LINC3 and LINC4)
暂无分享,去创建一个
M. Fleseriu | R. Auchus | P. Snyder | B. Biller | A. Heaney | J. Findling | Andreanne M. Lacroix | A. Pedroncelli | E. Geer | Julie M Silverstein | A. Piacentini